Continuous Glucose Monitor (CGM) Use in COVID-19 Patients

Overview

About this study

The purpose of this research is to determine if CGM (continuous glucose monitors) used in the hospital in patients with COVID-19 and diabetes treated with insulin will be as accurate as POC (point of care) glucose monitors. Also if found to be accurate, CGM reading data will be used together with POC glucometers to dose insulin therapy.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients 18 years or older.
  • Patients with diagnosis of COVID-19 respiratory infection.
  • Patient with recent positive SARS-COV2 infection and still positive PCR admitted of non-respiratory diagnoses.
  • Diagnosis of diabetes mellitus type 1 or type 2.
  • Diagnosis of medication (steroid) induced hyperglycemia (persistent glucose more than 180 mg/dl).
  • Taking insulin either SQ or IV.

Exclusion Criteria: 

  • Patient in shock.
  • Patient intubated on mechanical ventilation.
  • Patient placed on ECMO.
  • Patient taking hydroxyurea.
  • Patient taking more than 4g of acetaminophen in 24 hours or more than 1g acetaminophen in 6 hours.
  • Pregnant or nursing female patients.
  • Patients with skin lesions at the application site that may interfere with placement of the sensor.
  • Patients with known allergy to medical grade adhesive.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Adrian Dumitrascu, M.D.

Open for enrollment

Contact information:

Adrian Dumitrascu M.D.

(904) 956-0081

Dumitrascu.Adrian@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available

.
CLS-20509165

Mayo Clinic Footer